Feedback / Questions
Veltucyn (veltuzumab) - Immunomedics
Corporate Presentation
(Immunomedics)
-
Aug 15, 2011 -
Veltuzumab / Immunomedics; Anticipated top-line results in H2 '13 from VELVET trial
Anticipated top-line data
•
Immunology • None • Rheumatoid Arthritis
http://www.larvolonline.com/tlg/ccdb/ImmunomedicsCorporatePresentationAugust'11.pdf
Aug 15, 2011
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious